{"id":"W1977694976","doi":"10.1185/03007995.2013.836078","title":"Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2−advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre; University of Toronto","funders":"European Society for Medical Oncology; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Exemestane; Discontinuation; Internal medicine; Breast cancer; Quality of life (healthcare); Placebo; Confidence interval; Aromatase inhibitor; Hazard ratio; Oncology; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001058725,0.0004600706,0.001141603,0.0003645435,0.0001747724,0.0000416088,0.0002233853,0.0001711445,0.0005079255],"category_scores_gemma":[0.0004596511,0.0003164787,0.0000363794,0.0009217344,0.001364666,0.0003835738,0.0001142727,0.00104941,0.00000572545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008861318,"about_ca_system_score_gemma":0.002743139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002680394,"about_ca_topic_score_gemma":0.00008361019,"domain_scores_codex":[0.9942485,0.0005412974,0.0008687482,0.0008832319,0.002143086,0.001315121],"domain_scores_gemma":[0.9949223,0.000593586,0.000232923,0.0005159455,0.0005684496,0.003166772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1590643,0.001668811,0.0919591,0.002263363,0.0005356331,0.00008261343,0.004328646,0.0004382515,0.0001054966,0.0002777509,0.0002398226,0.7390362],"study_design_scores_gemma":[0.1206602,0.01997878,0.8219399,0.009521037,0.00005086361,0.0001625622,0.006166927,0.01587536,0.00002598006,0.000787392,0.003609976,0.001220999],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649037,0.02315901,0.0000878684,0.009536318,0.00007043043,0.002004646,0.0001402574,0.0000753813,0.00002244334],"genre_scores_gemma":[0.9839678,0.01450525,0.0001006785,0.0002143282,0.000164514,0.0007404685,0.0001630678,0.0000763113,0.00006758552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7378152,"threshold_uncertainty_score":0.9999287,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04616009174512354,"score_gpt":0.3891158325754402,"score_spread":0.3429557408303167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}